Get the Stockscreener App
254.17
2.25%
-5.86
After Hours:
254.17
Bio Rad Laboratories Inc Stock (BIO) Latest News
Hemoglobin A1c Testing Devices Market Projected To Witness - openPR
Learn to Evaluate (BIO) using the Charts - Stock Traders Daily
Does Bio-Rad Laboratories (NYSE:BIO) Have A Healthy Balance Sheet? - Simply Wall St
Cancer Biomarkers Market Size, Share, Growth Factors, - openPR
Blood Typing Analysis Report 2024: Market Set to Surge to $6.50 Billion by 2034, PCR and Microarray Techniques Pave the Way - GlobeNewswire Inc.
Blotting Machine Market Future Business Opportunities - openPR
Where are the Opportunities in (BIO.B) - Stock Traders Daily
The Future of Genetic Testing: Industry Growth, Trends & Key - openPR
Biomarker Research Services Market Projected To Witness Substantial Growth, 2025-2032:Bio-Rad Laboratories, - EIN News
Transcriptomics Technologies Market Future Business - openPR
Salmonella serotyping solution enhances food safety testing - Labmate Online
New XP-Design Assay Salmonella Serotyping Solution for Rapid, Accurate Food Safety Testing - Food Safety Magazine
Newborn Screening Market Growth in Future Scope 2025-2032 | - openPR
Charles Schwab Investment Management Inc. Boosts Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - Defense World
Laboratory Supplies Market Generated Opportunities, Future - openPR
Complement C4 Antibody Market Research 2025: Growing Focus on Precision Medicine and Targeted Therapies, and Increasing Investment in Immunotherapies and Biologic Drugs - GlobeNewswire Inc.
ChemiDoc Go Imaging System - The Scientist
HIV Rapid Test Kits Market Focused Insights 2025-2030: Abbott, Bio-Rad, and bioMerieux Strengthen Market Position Amid Rising Competition - Yahoo Finance
Stem Cell Assay Market Demand, Industry Growth and Future Scope - openPR
Empowering Growth: Vector Purification Market 2025 - openPR
Clinical Biomarkers Market Key Players Analysis- Johnson & - openPR
Expanded kit range enhances AAV vector characterisation - Labmate Online
Neurological Biomarkers: Global Market Review 2020-2024 and - GlobeNewswire
Neurological Biomarkers: Global Market Review 2020-2024 and Forecast to 2030, Featuring Analysis of PerkinElmer, Abbott Labs, Thermo Fisher Scientific, Banyan Biomarkers, Bio-Rad Labs & More - Yahoo Finance
High-Performance Liquid Chromatography Market Top Players - openPR
Genomics Market Expansion | Future Trends & Investment Insights - openPR
Bio-Rad stock touches 52-week low at $248.05 amid market shifts - Investing.com Australia
Bio-Rad stock touches 52-week low at $248.05 amid market shifts By Investing.com - Investing.com South Africa
Cancer Monoclonal Antibodies Market Is Booming Worldwide | Abnova Corporation, BioGenex, Bio-Rad Laboratories - openPR
Blood Cancer Diagnostics Market Analysis Report 2025-2030, with Quest Diagnostics, Illumina, InVivoScribe, Asuragen, Danaher, Sequenta, SkylineDx, Bio-Rad Laboratories, Alercell & Sophia Genetics - Yahoo Finance
Zacks Research Has Negative Outlook of BIO Q1 Earnings - Defense World
Proteomics Market Projected To Witness Substantial Growth, 2025-2032: Bio-Rad Laboratories, Inc., GE - EIN News
Zacks Research Issues Pessimistic Outlook for BIO Earnings - Defense World
Bio-Rad Laboratories, Inc. (NYSE:BIO) is a favorite amongst institutional investors who own 60% - Yahoo Finance
Japan In-Vitro Diagnostics Market Forecast Report and - GlobeNewswire
Japan In-Vitro Diagnostics Market Forecast Report and Company Analysis 2025-2033 Featuring Abbott, Danaher, Biomerieux, Roche, Becton, Sysmex, Bio-Rad Laboratories, Thermofisher Scientific - Yahoo Finance
Bio-Rad Laboratories, Inc. Class A to Host Earnings Call - ACCESS Newswire
Protein A Resin Market: Growth, Trends, Key Players, - openPR
How to Take Advantage of moves in (BIO.B) - Stock Traders Daily
Polyclonal Antibody Market Growth: Impact on Healthcare & - openPR
Protein Chip Market Detailed In New Research Report 2025 | Agilent Technologies, PerkinElmer, Bio-Rad Laboratories - openPR
Is Bio-Rad Laboratories, Inc. (BIO) the Best Medical Technology Stock to Buy According to Analysts? - Insider Monkey
Life Science Products Market Detailed In New Research Report - openPR
High-Throughput Screening Technology Analysis and Global - GlobeNewswire
High-Throughput Screening Technology Analysis and Global Markets 2021-2024 & 2025-2029 with Danaher, Thermo Fisher Scientific., Charles River Laboratories, Revvity and Bio-Rad Laboratories Leading - Yahoo Finance
Bay Area biotech giant Bio-Rad to lay off hundreds after $1.8 billion loss - MSN
Bio-Rad Laboratories, Inc. (NYSE:BIO) Stock Holdings Lessened by Hosking Partners LLP - MarketBeat
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Veritas Asset Management LLP - MarketBeat
Blackhawk Capital Partners LLC. Purchases 1,427 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Fjarde AP Fonden Fourth Swedish National Pension Fund Purchases 1,200 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
New York State Common Retirement Fund Sells 1,000 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - Defense World
7 Best Medical Technology Stocks To Buy According To Analysts - Insider Monkey
Bio-Rad stock touches 52-week low at $262.11 amid market shifts - Investing.com
Tech, life science companies slash hundreds more Bay Area workers - MSN
Some Confidence Is Lacking In Bio-Rad Laboratories, Inc. (NYSE:BIO) As Shares Slide 28% - Simply Wall St
Analyzing the Potential $677 Million Expression Vectors - GlobeNewswire
Principal Financial Group Inc. Sells 234 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - Defense World
Sample Preparation Market Key Players AnalysisMerck KgaA, - openPR
Minimal Residual Disease Testing Market Expanding with - openPR
Bio-Rad (BIO) International Revenue Performance Explored - Yahoo Finance
Truist Financial Corp Purchases 72 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - Defense World
How to Take Advantage of moves in (BIO) - Stock Traders Daily
Capillary Electrophoresis Market Report 2025-2030, with Profiles of Bio-Rad Laboratories, Bio-Techne, Qiagen, Helena Laboratories, Agilent Technologies, PerkinElmer, Danaher, Merck, Shimadzu & more - Yahoo Finance
1.34%
0.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):